FCH
TECH icon

Freestone Capital Holdings’s Bio-Techne TECH Stock Holding History

Freestone Capital Holdings’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-52
Closed -$4.13K – 1052
2020
Q4 		$4.13K Hold
52
– – ﹤0.01% 1035
2020
Q3 		$3.22K Buy
+52
New +$3.38K ﹤0.01% 960

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Freestone Capital Holdings's TECH Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 52 shares — an estimated $4.13K sold.

Freestone Capital Holdings first reported a position in TECH in Q3 2020 and held it in 2 quarters. The position peaked at $4.13K in Q4 2020. 470 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 52 Bio-Techne shares in Q1 2021, an estimated $4.13K.
  • Freestone Capital Holdings first reported a position in Bio-Techne in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Bio-Techne position peaked at $4.13K in Q4 2020.
  • 470 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.